Integration of the extranuclear and nuclear actions of estrogen

Molecular Endocrinology

Volumn 19, Issue 8, 2005, Pages 1951-1959

  Levin, Ellis R ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RALOXIFENE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN;

BREAST CANCER; CELL DEATH; CELL FUNCTION; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CROSS REACTION; CYTOLOGY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ESTROGEN ACTIVITY; GENETIC TRANSCRIPTION; MITOCHONDRION; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; ESTROGENS; GTP-BINDING PROTEINS; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; STEROIDS;

EID: 23744447497     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0390     Document Type: Short Survey

References (99)

1. Jensen EV, Jacobson HI 1962 Basic guides to the mechanism of estrogen action. Recent Prog Horm Res 18:387-414
2. Levin ER 2001 Cell Localization, physiology and nongenomic actions of estrogen receptors. J Applied Physiol 91:1860-1867
3. Kushner PJ, Agard D, Feng WJ, Lopez G, Schiau A, Uht R, Webb P, Greene G 2000 Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp 230:20-26
4. Mandava MB 1988 Plant growth-promoting brassinosteroids. Annu Rev Plant Physiol Plant Mol Biol 39:23-52
5. Wang ZY, Seto H, Fujioka S, Yoshida S, Chory J 2001 BRl1 is a critical component of a plasma-membrane receptor for plant steroids. Nature 410:380-383
6. Qin C, Samudio I, Ngwenya S, Safe S 2004 Estrogen-dependent regulation of ornithine decarboxylase in breast cancer cells through activation of nongenomic cAMP-dependent pathways. Mol Carcinog 40:160-170
7. Watters JJ, Chun TY, Kim YN, Bertics PJ, Gorski J 2000 Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol Endocrinol 14:1872-1881
8. Razandi M, Pedram A, Rosen E, Levin ER 2004 BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 24:5900-5913
9. Pappas TC, Gametchu B, Yannariello-Brown J, Collins TJ, Watson CS 1995 Membrane estrogen receptors identified by multiple antibody labeling and impeded ligand binding. FASEB J 9:404-410
10. Norfleet AM, Thomas ML, Gametchu B, Watson CS 1999 Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140:3805-3814
11. Razandi M, Pedram A, Greene GL, Levin ER 1999 Cell membrane and nuclear estrogen receptors derive from a single transcript: studies of ERα and ERβ expressed in CHO cells. Mol Endocrinol 13:307-319
12. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW 2002 ERβ has nongenomic action in caveolae. Mol Endocrinol 16:938-946
13. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER 2004 Plasma membrane estrogen receptors exist and function as dimers. Mol Endocrinol 18:2854-2865
14. Li L, Haynes MP, Bender JR 2003 Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100:4807-4812
15. Pendaries C, Darblade B, Rochaix P, Krust A, Chambon P, Korach KS, Bayard F, Arnal JF 2002 The AF-1 activation-function of ERα may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci USA 99:2205-2210
16. Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK, Kelly MJ 2003 Rapid signaling of estrogen in hypothalamic neurons involves a novel G-proteincoupled estrogen receptor that activates protein kinase C. J Neurosci 23:9529-9540
17. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly Jr ES, Nethrapalli IS, Tinnikov AA 2002 ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 19:8391-8401
18. Singh M, Setalo Jr G, Guan X, Warren M, Toran-Allerand CD 1999 Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci. 19:1179-1188
19. Nakhla AM, Romas NA, Rosner W 1997 Estradiol activates the prostate androgen receptor and prostate-specific antigen secretion through the intermediacy of sex hormone binding globulin. J Biol Chem 272:6838-6841
20. Filippi S, Luconi M, Granchi S, Vignozzi L, Bettuzzi S, Tozzi P, Ledda F, Forti G, Maggi M 2002 Estrogens, but not androgens, regulate expression and functional activity of oxytocin receptor in rabbit epididymis. Endocrinology 143:4271-4280
21. Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM, Shaul PW 2001 Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Gα(i). J Biol Chem 276:27071-27076
22. Kelly MJ, Qiu J, Wagner EJ, Ronnekleiv OK 2002 Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS). J Steroid Biochem Mol Biol 83:187-193
23. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER 2002 Estrogen receptors associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16:100-115
24. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ 2002 Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99:14783-14788
25. Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ 2004 The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane. Proc Natl Acad Sci USA 101:2076-2081
26. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I 1999 Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae. Biochem Biophys Res Commun 263:257-262
27. Benten WP, Stephan C, Lieberherr M, Wunderlich F 2001 Estradiol signaling via sequestrable surface receptors. Endocrinology 142:1669-1677
28. Stevis PE, Deecher DC, Suhadolnik L, Mallis LM, Frail DE 1999 Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 140:5455-5458
29. Tiruppathi C, Naqvi T, Wu Y, Vogel SM, Minshall RD, Malik AB 2004 Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells. Proc Natl Acad Sci USA 101:7699-7704
30. Filardo EJ, Quinn JA, Frackelton Jr AR, Bland KI 2002 Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84
31. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, Andò S 2004 The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 279:27008-27016
32. Ahola TM, Manninen T, Alkio N, Ylikomi T 2002 G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells. Endocrinology 143:3376-3384
33. Thomas P, Pang Y, Filardo EJ, Dong J 2005 Identity of an estrogen membrane receptor coupled to a G-protein in human breast cancer cells. Endocrinology 146:624-632
34. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F 2000 Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J 19:5406-5417
35. Razandi M, Pedram A, Levin ER 2000 Estrogen signals to preservation of endothelial cell form and function. J Biol Chem 275:38540-38546
36. Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH 2004 Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor α. Proc Natl Acad Sci USA 101:17126-17131
37. Chambliss KL, Simon L, Yuhanna IS, Mineo C, Shaul PW 2005 Dissecting the basis of nongenomic activation of eNOS by estradiol: role of ERα domains with known nuclear functions. Mol Endocrinol 19:277-289
38. Razandi M, Alton G, Pedram A, Ghonshani S, Webb D, Levin ER 2003 Identification of a structural determinant for the membrane localization of ERα. Mol Cell Biol 23:1633-1646
39. Song RX, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ 2002 Linkage of rapid estrogen action to MAPK activation by ER α-Shc association and Shc pathway activation. Mol Endocrinol 16:116-127
40. Acconcia F, Ascenzi P, Fabozzi G, Visca P, Marino M 2004 S-palmitoylation modulates human estrogen receptor-α functions. Biochem Biophys Res Commun 316:878-883
41. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, Marino M 2005 Palmitoylatindependent estrogen receptor α membrane localization regulation by 17 β-estradiol. Mol Biol Cell 16:231-237
42. Razandi M, Pedram A, Parks S, Levin ER 2003 Proximal events in ER signaling from the plasma membrane. J Biol Chem 278:2701-2712
43. Zhang Z, Maier B, Santen RJ, Song RX 2002 Membrane association of estrogen receptor α mediates estrogen effect on MAPK activation. Biochem Biophys Res Commun 294:926-933
44. Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC 2003 Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111:1651-1664
45. Keshamouni VG, Mattingly RR, Reddy KB 2002 Mechanism of 17-β-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER-2 and PKC-β. J Biol Chem 277:22558-22565
46. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C 2000 Estrogen receptor α rapidly activates the IGF-1 receptor pathway. J Biol Chem 275:18447-18453
47. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, et al 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
48. Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE, Stoica A 2000 A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141:4503-4511
49. Balasenthil S, Barnes CJ, Rayala SK, Kumar R 2004 Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. FEBS Lett 567:243-247
50. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
51. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides RJ 1997 CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415
52. Lopez GN, Turck CW, Schaufele F, Stallcup MR, Kushner PJ 2001 Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J Biol Chem 276:22177-22182
53. Iwase H 2003 Molecular action of the estrogen receptor and hormone dependency in breast cancer. Breast Cancer 10:89-96
54. Michalides R, Griekspoor A, Balkenende A, Verwoerd D, Janssen L, Jalink K, Floore A, Velds A, van't Veer L, Neefjes J 2004 Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer. Cancer Cell 5:597-605
55. Yamakawa K, Arita J 2004 Cross-talk between the estrogen receptor-, protein kinase A-, and mitogen-activated protein kinase-mediated signaling pathways in the regulation of lactotroph proliferation in primary culture. J Steroid Biochem Mol Biol 88:123-130
56. Jordan VC 2004 Selective estrogen receptor modulation: concept and consequences in cancer. Cancer Cell 5:207-213
57. Duan R, Xie W, Li X, McDougal A, Safe S 2002 Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells. Biochem Biophys Res Commun 294:384-394
58. Pedram A, Razandi M, Aitkenhead M, Hughes CCW, Levin ER 2002 Integration of the non-genomic and genomic actions of estrogen: membrane initiated signaling by steroid (MISS) to transcription and cell biology. J Biol Chem 277:50768-50775
59. Gately S, Li WW 2004 Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol 31(Suppl 7):2-11
60. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK 1998 The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95:13513-13518
61. Liang J, Slingerland JM 2003 Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2:339-345
62. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S 2002 The protein kinase complement of the human genome. Science 298:1912-1934
63. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-72
64. Datta SR, Brunet A, Greenberg ME 1999 Cellular survival: a play in three Akts. Genes Dev 13:2905-2927
65. Proud, CG 2004 Role of mTOR signalling in the control of translation initiation and elongation by nutrients. Curr Top Microbiol Immunol 279:215-244
66. Plotkin LI, Aguirre JI, Kousteni S, Manolagas SC, Bellido T 2005 Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of ERK activation. J Biol Chem 280:7317-7325
67. Chen JR, Plotkin LI, Aguirre JI, Han L, Jilka RL, Kousteni S, Bellido T, Manolagas SC 2005 Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti- versus Pro-apoptotic effects of estrogens. J Biol Chem 280:4632-4638
68. Bartucci M, Morelli C, Mauro L, Ando' S, Surmacz E 2001 Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res 61:6747-6754
69. Meyer G, Feldman EL 2002 Signaling mechanisms that regulate actin-based motility processes in the nervous system. J Neurochem 83:490-503
70. Schafer DA 2004 Barbed ends rule. Nature 430:734-735
71. Kipp JL, Ramirez VD 2001 Effect of estradiol, diethylstilbestrol, and resveratrol on F0F1-ATPase activity from mitochondrial preparations of rat heart, liver, and brain. Endocrine 15:165-175
72. Stojanovski D, Johnston AJ, Streimann I, Hoogenraad NJ, Ryan MT 2003 Import of nuclear-encoded proteins into mitochondria. Exp Physiol 88:57-64
73. Chen JQ, Delannoy M, Cooke C, Yager JD 2004 Mitochondrial localization of ERα and ERβ in human MCF7 cells. Am J Physiol Endocrinol Metab 286:E1011-E1022
74. Yang SH, Liu R, Perez EJ, Wen Y, Stevens Jr SM, Valencia T, Brun-Zinkernagel AM, Prokai L, Will Y, Dykens J, Koulen P, Simpkins JW 2004 Mitochondrial localization of estrogen receptor β. Proc Natl Acad Sci USA 101:4130-4135
75. Huang P, Oliff A 2001 Signaling pathways in apoptosis as potential targets for cancer therapy. Trends Cell Biol 11:343-348
76. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730
77. Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298:843-846
78. Stoica GE, Franke TF, Moroni M, Mueller S, Morgan E, Iann MC, Winder AD, Reiter R, Wellstein A, Martin MB, Stoica A 2003 Effect of estradiol on estrogen receptor-α gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene 22:7998-8011
79. Marquez DC, Pietras RJ 2001 Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 20:5420-5430
80. Simoncini T, Genazzani AR, Liao JK 2002 Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation 105:1368-1373
81. Hisamoto K, Ohmichi M, Kanda Y, Adachi K, Nishio Y, Hayakawa J, Mabuchi S, Takahashi K, Tasaka K, Miyamoto Y, Taniguchi N, Murata Y 2001 Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal-regulated protein kinase in vascular endothelial cells. J Biol Chem 276:47642-47649
82. Ogita H, Node K, Asanuma H, Sanada S, Kim J, Takashima S, Minamino T, Hori M, Kitakaze M 2004 Raloxifene improves coronary perfusion, cardiac contractility, and myocardial metabolism in the ischemic heart: role of phosphatidylinositol 3-kinase/Akt pathway. J Cardiovasc Pharmacol 43:821-829
83. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541
84. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM 1998 Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18:1253-1258
85. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, Kindy MS, Wise PM 2001 Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 98:1952-1957
86. Rau SW, Dubal DB, Bottner M, Gerhold LM, Wise PM 2003 Estradiol attenuates programmed cell death after stroke-like injury. J Neurosci 23:11420-11426
87. Simpkins JW, Yang SH, Liu R, Perez E, Cai ZY, Covey DF, Green PS 2004 Estrogen-like compounds for ischemic neuroprotection. Stroke 35(Suppl 1):2648-2651
88. Yu X, Rajala RV, McGinnis JF, Li F, Anderson RE, Yan X, Li S, Elias RV, Knapp RR, Zhou X, Cao W 2004 Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 β-estradiol-mediated neuroprotection. J Biol Chem 279:13086-13094
89. Wilson ME, Liu Y, Wise PM 2002 Estradiol enhances Akt activation in cortical explant cultures following neuronal injury. Brain Res Mol Brain Res 102:48-54
90. Jung ME, Watson DG, Wen Y, Simpkins JW 2003 Role of protein kinase C in estrogen protection against apoptotic cerebellar cell death in ethanol-withdrawn rats. Alcohol 31:39-48
91. Xu Y, Traystman RJ, Hurn PD, Wang MM 2003 Neurite-localized estrogen receptor-α mediates rapid signaling by estrogen. J Neurosci Res 74:1-11
92. Behl C 2002 Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3:433-442
93. Abraham IM, Todman MG, Korach KS, Herbison AE 2004 Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain. Endocrinology 145:3055-3061
94. Richards JS, Sharma SC, Falender AE, Lo YH 2002 Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins. Mol Endocrinol 16:580-599
95. Kimura A, Ohmichi M, Kawagoe J, Kyo S, Mabuchi S, Takahashi T, Ohshima C, Arimoto-Ishida E, Nishio Y, Inoue M, Kurachi H, Tasaka K, Murata Y 2004 Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 23:4505-4515
96. Mazumdar A, Kumar R 2003 Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells. FEBS Lett 535:6-10
97. Santen RJ, Song RX, Zhang Z, Yue W, Kumar R2004 Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer. Clin Cancer Res 10:337S-345S
98. Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, Schiff R 2004 Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J Natl Cancer Inst 96:926-935
99. Liu H, Lee ES, Gajdos C, Pearce ST, Chen B, Osipo C, Loweth J, McKian K, De Los Reyes A, Wing L, Jordan VC 2003 Apoptotic action of 17β-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo. J Natl Cancer Inst 95:1586-1597